FDA Clears Gen-Probe’s sexually transmitted disease (STD) diagno
Gen-Probe Inc. (NYSE: GPRO) announced on May 8 that the U.S. Food and Drug Administration (FDA) has cleared its PANTHER system, an automated sexually transmitted disease diagnostics platform. The sys
Read More
